Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Taste receptor type 1 member 3 (T1R3) is a class C GPCR that, as a homodimer, functions as a glucose-sensing receptor in pancreatic β-cells. Unlike the canonical sweet taste receptor of the tongue (a T1R2/T1R3 heterodimer), the β-cell variant is primarily the T1R3 homodimer. Activation of T1R3 by glucose or artificial sweeteners stimulates insulin secretion by modulating intracellular signaling cascades involving GPCR/PLC-mediated calcium mobilization. Knockdown or genetic ablation of T1R3 impairs normal glucose-stimulated insulin release and disrupts glucose metabolism, which highlights its physiological relevance and potential as a therapeutic target in diabetes and metabolic disease.
Activation of T1R3 by glucose or sweeteners increases intracellular calcium via the GPCR/PLCβ2 pathway, leading to cAMP elevation and insulin granule exocytosis. Sweetener or glucose binding activates T1R3, leading to PLC activation, IP3-mediated Ca2+ release, and augmented insulin secretion.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taste receptor type 1 member 3 (T1R3), as a homodimer acting as a glucose-sensing receptor in pancreatic β-cells (T1R3).